a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IVFCX | 3.69 | 0.02 | +0.54% |
Federated Hermes Intl Strat Val Div C | |||
VFAIX | 52.45 | 0.27 | +0.52% |
Vanguard Financials Index Admiral | |||
HRLVX | 23.32 | 0.12 | +0.52% |
Harbor Large Cap Value Admin | |||
GMEPX | 18.84 | N/A | N/A |
Goldman Sachs China Equity P | |||
KCGSX | 18.75 | -0.16 | -0.85% |
Knights of Columbus Large Cap Growth S |
A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with RVNC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then RVNC could also see price increases.
Ticker / NAME | Correlation To ORIC | 1D Price Change % | ||
---|---|---|---|---|
ORIC | 100% | +4.27% | ||
RVNC - ORIC | 40% Loosely correlated | -4.33% | ||
SVRA - ORIC | 39% Loosely correlated | +1.44% | ||
ERAS - ORIC | 39% Loosely correlated | +5.14% | ||
PTGX - ORIC | 39% Loosely correlated | -0.76% | ||
ACLX - ORIC | 39% Loosely correlated | +0.95% | ||
More |